Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal ...

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence. Despite its rarity and the lack of recognition by the World Health Organization as a ...

The US Food and Drug Administration (FDA) approved the first CAR T-cell therapies in 2017 for diffuse large B-cell lymphoma and acute lymphoblastic leukemia in pediatric and young adult patients.

Researchers are looking into new treatments for acute lymphoblastic leukaemia as well as ways to reduce the side effects treatment can cause. There are a number of clinical trials for children to join ...

Leukemia is the most common type of cancer in children, with an annual incidence of about 5 per 100,000 children in the United States. Up to 20–30% of patients with acute leukemia develop ...

Chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL ... What is the difference between acute and chronic leukemia? The key difference between acute and chronic leukemia is ...

It is important for people living with chronic lymphocytic leukemia (CLL) to take care of their mental and physical health. Tips to manage day-to-day include getting enough rest and talking with ...

To overcome this, researchers used human T-cells and leukemia cells in specialized mouse models to develop ALA-CART, which showed promising results against acute lymphocytic leukemia (ALL) that had ...

Hematopoietic and lymphocytic neoplasms (HLNs ... and potential progression to acute myeloid leukemia (AML). Genetic abnormalities, including deletions (5q-, 7q-, 20q-) and mutations in splicing ...